IRIDEX Corporation (IRIX) Financials
IRIX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 34.9 million | 22.9 million |
2023-06-30 | 36.9 million | 23.5 million |
2023-03-31 | 41.0 million | 25.1 million |
2022-12-31 | 42.3 million | 25.1 million |
IRIX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.9 million | 371000 |
2023-06-30 | -1.2 million | 400000 |
2023-03-31 | -2.9 million | 473000 |
2022-12-31 | -1.7 million | 516000 |
IRIX Net Income
No data available :(
IRIX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 8.0 million | - | 995000 |
2023-06-30 | 9.8 million | - | 1.3 million |
2023-03-31 | 11.0 million | - | 1.5 million |
2022-12-31 | 13.9 million | - | 1.8 million |
IRIX Shares Outstanding
IRIX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 82000 | 1.5 million | 1.9 million | 3.8 million |
2023-06-30 | 16000 | 1.8 million | 2.1 million | 4.3 million |
2023-03-31 | 43000 | 1.7 million | 2.3 million | 4.3 million |
2022-12-31 | 83000 | 1.5 million | 1.8 million | 4.8 million |
IRIX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 12.9 million | 7.2 million |
2023-06-30 | 12.9 million | 7.5 million |
2023-03-31 | 13.7 million | 7.8 million |
2022-12-31 | 15.2 million | 8.5 million |
IRIX
Price: $2.80
52 week price:
Earnings Per Share: -0.59 USD
P/E Ratio: -5.54
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 10931
Ebitda: -2.8 millionMarket Capitalization: 54.4 million